Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma

Robert J. Motzer, David F. McDermott, Bernard Escudier, Mauricio Burotto, Toni K. Choueiri, Hans J. Hammers, Philippe Barthélémy, Elizabeth R. Plimack, Camillo Porta, Saby George, Thomas Powles, Frede Donskov, Howard Gurney, Christian K. Kollmannsberger, Marc Oliver Grimm, Carlos Barrios, Yoshihiko Tomita, Daniel Castellano, Viktor Grünwald, Brian I. RiniM. Brent McHenry, Chung Wei Lee, Jennifer McCarthy, Flavia Ejzykowicz, Nizar M. Tannir

Research output: Contribution to journal › Article › peer-review

123 Scopus citations

Fingerprint

Dive into the research topics of 'Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences